Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Allogene Therapeutics (ALLO) - P/B ratio
P/B ratio as of May 2024 : 0.9899
According to Allogene Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.9899.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Allogene Therapeutics - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.05 | -22.47% |
| 2022-12-31 | 1.36 | -40.82% |
| 2021-12-31 | 2.30 | -29.92% |
| 2020-12-31 | 3.28 | -34.86% |
| 2019-12-31 | 5.03 | 8.22% |
| 2018-12-31 | 4.65 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 189.36% | 🇺🇸 USA |